The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1538
January 15, 2018
View Complete Issue         Table of Contents 2019 
Drugs for GERD and Peptic Ulcer Disease
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for GERD and Peptic Ulcer Disease
January 15, 2018 (Issue: 1538)
Gastroesophageal reflux disease (GERD) is the most frequent GI condition encountered in the outpatient setting; it affects about 20% of the US population. Heartburn and regurgitation are the classic symptoms of GERD.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for GERD and Peptic Ulcer Disease
Article code: 1538a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.